Future Program: Laguna
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEF ADVANCED RESEARCH PROJECTS AGCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
DARPA-SN-27-15
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AC12
Additional Details
Documents1
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has issued a Special Notice to inform the public of forthcoming research opportunities under the anticipated Laguna program. This notice, identified by procurement number DARPA-SN-27-15, serves as an early notification of DARPA/BTO’s intent to solicit innovative research proposals in areas relevant to the Laguna initiative. While the full solicitation has not yet been released, interested parties are advised that it will be made available via the official government procurement portal at https://sam.gov/ upon publication. The notice may also be updated with a draft solicitation as program details are finalized.
The Laguna program falls under the North American Industry Classification System (NAICS) code 541714, which pertains to Research and Development in Biotechnology (except Nanobiotechnology). This classification indicates a focus on advanced biotechnological research, excluding nanobiotechnology, and suggests that DARPA is seeking expertise in cutting-edge biological sciences and technology development. The associated Product Service Code (PSC) is AC12, further specifying the requirement for research and development services in the life sciences domain.
DARPA’s Biological Technologies Office is renowned for advancing transformative research at the intersection of biology and technology, with the goal of delivering novel capabilities to the Department of Defense. The Laguna program is expected to align with this mission, seeking proposals that address emerging challenges and opportunities in biotechnology. While specific technical objectives and deliverables have not yet been detailed, the notice signals DARPA’s interest in engaging with the research community to explore new frontiers in biological technologies.
The contracting entity for this opportunity is the Defense Advanced Research Projects Agency, a federal office within the Department of Defense. The primary point of contact for inquiries related to the Laguna program is Dr. William Mounfield, who can be reached via email at [email protected]. Prospective offerors are encouraged to monitor the SAM.gov listing (Opportunity ID: 9fe8c170741e474390b14912d103fd99) for updates, including the release of the full solicitation and any associated attachments.
This procurement is currently classified as a Special Notice, which typically serves to inform and engage the research and development community prior to the formal solicitation process. No set-aside requirements or special considerations have been specified at this stage. The notice remains active, with a response deadline set for November 30, 2026.
Contractors with capabilities in advanced biotechnology research and development, particularly those experienced in supporting defense-related initiatives, are encouraged to review this opportunity closely. The Laguna program represents a significant potential avenue for contributing to DARPA’s mission of pioneering technological innovation in support of national security objectives.